Navigation Links
World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research
Date:5/8/2008

a San Francisco

"This is truly an exciting time for the Cancer Research Alliance," said Chairperson, Bridget Brennan. "By engaging all Americans in the Infinite Power of One(TM) campaign, we know we can galvanize the public to make change and celebrate the infinite power we have as a society to have a positive impact on our health. The CRA will use the funds generated from this campaign to accelerate research that is less invasive, more targeted, more personal and more powerful."

"Celebrations.com and 1-800-FLOWERS.COM(R) are proud to sponsor the Infinite Power of One(TM) campaign," said Seth Lasser, Executive Editor and General Manager, Celebrations.com. "We are proud to join forces with Americans and the Cancer Research Alliance to celebrate the infinite power that we can have on this important health issue when we collaborate our efforts as a society to take action and accelerate change."

Cancer is the second most common cause of death in the US after heart disease. More than 1,437,000 new cancer cases are expected to be diagnosed in 2008. This year, more than 565,000 Americans will die, more than 1,500 people a day. In the US, cancer accounts for 1 of every 4 deaths.

"Patients and families are often intrigued and inspired by our research, but often don't believe a small donation can make a difference," said Donald L. Trump, MD, FACP, President and CEO of Roswell Park Cancer Institute. "We hope that this campaign demonstrates that each dollar counts -- just as every single minute in the laboratory counts -- and that collectively, we can make a significant impact for tomorrow's cures."

To support the campaign, please visit http://www.celebrations.com

ABOUT THE CANCER RESEARCH ALLIANCE

The Cancer Research Alliance (CRA) is a 501(C)(3) nonprofit organization comprised of 12 of the nation's top cancer centers. The CRA was founded in 2006 as a way to unite the nati
'/>"/>

SOURCE Cancer Research Alliance
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
2. Aspirin Named 8th World Wonder by Majority of Americans
3. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
4. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
5. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
6. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
7. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
8. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
11. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/13/2008)...., May 13 /- Dried blood spots are em...serum collection and transport,for blood tests. In...l of,Diabetes Science and Technology (2008; 2(2):2...e use of dried blood spots is a "powerful tool", f...developing countries with,limited health budgets.,...
(Date:5/13/2008)... and BARCELONA, Spain, May 13 /PRNewswire-FirstCal...today welcomed two-year results,from the SPIRIT II...roven,long-term safety and efficacy of the market-...oronary Stent System and reinforce the growing bod... V (PROMUS(TM)),Everolimus-Eluting Coronary Stent ...
(Date:5/13/2008)...ted with XIENCE V in SPIRIT III Trial Experience B... Stent Thrombosis than Patients ... 13 /- Long-term data,prese...trial, Abbott,s U.S.,pivotal trial studying the XI...m, demonstrated that XIENCE V continues to deliver...
(Date:5/13/2008)...LIS, France, May 13 /- NicO...& Co., Inc. has initiated the,first in a series of...ertensive patients, under the companies, collabora...g antihypertensive agents using NicOx,proprietary...elected from,the companies, joint research program...
Breaking Medicine Technology:Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening 2SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents 2SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents 3SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents 4XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 2XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 3XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 4XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 5NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc. 2NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc. 3African medical research and training receives Wellcome boost 16519 1African medical research and training receives Wellcome boost 16519 2SAPPHIRE trial shows long term benefit of carotid stenting as alternative to surgery 16517 1SAPPHIRE trial shows long term benefit of carotid stenting as alternative to surgery 16517 2SAPPHIRE trial shows long term benefit of carotid stenting as alternative to surgery 16517 3Study Showed Minimally Invasive Surgery Reduced Risk of Hospital Acquired Infections Compared to Open Surgery 16516 1Study Showed Minimally Invasive Surgery Reduced Risk of Hospital Acquired Infections Compared to Open Surgery 16516 2Study Showed Minimally Invasive Surgery Reduced Risk of Hospital Acquired Infections Compared to Open Surgery 16516 3Rejuvasun 28TM 29 With Omnilux 28TM 29 3A Industry First to Feature FDA Cleared Clinically Proven Light Therapy Technology 16514 1Rejuvasun 28TM 29 With Omnilux 28TM 29 3A Industry First to Feature FDA Cleared Clinically Proven Light Therapy Technology 16514 2Rejuvasun 28TM 29 With Omnilux 28TM 29 3A Industry First to Feature FDA Cleared Clinically Proven Light Therapy Technology 16514 3
...RE)--Jun 18, 2007 - Advanced Viral,Research Corp. ...company, announced today that preliminary findings...ow topical treatment with AVR118,appears to have c...ess associated with surgical incisions or dermatol...ological study is evaluating the,activity of a top...
...Influenza Conference , HIGH WYCOMBE, UK 18th June ...ing how a new flu vaccine has the potential,to pro...andemic and,annual, was presented today by PepTcel...a VI (Options) Conference, in Toronto,Canada. , T...n the,European Journal of Immunology, showed how m...
Other Medicine Technology:Advanced Viral Research Corp. Announces Positive Preliminary,Findings from Ongoing Phase II Dermatological Study 2New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 5
(Date:5/13/2008)...-- United American Healthcare,Corporation (Nasdaq:...nagement services to a full-service managed care o...l results for its third fiscal quarter,ended March... million for the third fiscal,quarter ended March ...or,the third quarter of the prior fiscal year. The...
(Date:5/13/2008)...re-FirstCall/ -- IRIDEX,Corporation (Nasdaq: IRIX...quarter of 2008 ended March 29, 2008., Revenue fo...8.7%,decrease from the $12.6 million reported for ...was $0.9 million or $0.10 per diluted share for th...f $4.9 million or $0.61 per,diluted share in the f...
(Date:5/13/2008)... Ongoing; Company Prepares for, Potential 2008 Lau...llion in Quarter, G...iddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ),...d commercializing novel anti-infective products, t...or the quarter ended March 31,2008., MiddleBrook...
(Date:5/13/2008)... the poor from improving, study finds , ,...of care at hospitals that treat poor and underserv... lagging well behind hospitals that do not serve t...tals, which rely on state and federal funding from... to improve the quality of care at the same rate t...
Breaking Medicine News(10 mins):Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 2Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 3Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 4Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 5Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 6Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 7Health News:IRIDEX Reports First Quarter 2008 Financial Results 2Health News:IRIDEX Reports First Quarter 2008 Financial Results 3Health News:IRIDEX Reports First Quarter 2008 Financial Results 4Health News:IRIDEX Reports First Quarter 2008 Financial Results 5Health News:IRIDEX Reports First Quarter 2008 Financial Results 6Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 2Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 3Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 4Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 5Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 6Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 7Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 8Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 9Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 10Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 11Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 12Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 13Health News:Quality Lags at Safety-Net Hospitals 2Health News:Quality Lags at Safety-Net Hospitals 3
...acteria known as E. coli 0157:H7 causes some of th...en and adults. Infections with this organism are o...udy shows using antibiotics to treat children with...he risk of developing a potentially deadly liver d...
...ysfunction is associated with loss of libido, low ...men who have attained their menopause or whose ova...Dehydroepiandosterone(DHEA), may serve as an effec...n, according to a study released at the 96th annua...
...cal Association (IMA) is embarking on an exercise ...country, according to Dr. Sanjiv Malik, Honorary S...so entered into an alliance with ORGMARG to create...ners in the country, be it allopathy or homeopathy...
...isclosure, Dr. Murali Ankem, a resident in Urology... University of New Jersey Medical and Dental Schoo...sed in prostate cancer treatment can migrate to ot...s. In a procedure called Brachytherapy, tiny metal...
Other Medicine News:
Tegagel hydrogel wound filler and Tegagel hydrogel wound filler with gauze are amorphous hydrogel dressings specially formulated to help provide a moist environment that has been shown to enhance wou
... physician preference card system as well as a per...ply management requirements of the surgical servic... with a broad array of inventory management capabi...suite supply and charge capture workflow. Regardle...
...rade; External Vacuum Therapy System restores sexu...ive and low cost vacuum therapy, coupled with its ..., makes it the ideal therapy for treating erectile... System causes penile rigidity that can be maintai...
Easy to Use manual vacuum system features a pumping mechanism that can be operated with one hand.
Medicine Products: